Evidence map›Paper›PMID 25404333›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

VEGF-B selectively regenerates injured peripheral neurons and restores sensory and trophic functions.

Victor H Guaiquil, Zan Pan, Natalia Karagianni, Shima Fukuoka, Gemstonn Alegre, Mark I Rosenblatt

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
4.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 119 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Unleashing Intrinsic Growth Pathways in Regenerating Peripheral Neurons.International journal of molecular sciences · 2022
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Victor H GuaiquilMargaret M. Dyson Vision Research Institute, Department of Ophthalmology, Weill Cornell Medical College, New York, NY 10065.
Zan PanMargaret M. Dyson Vision Research Institute, Department of Ophthalmology, Weill Cornell Medical College, New York, NY 10065.
Natalia KaragianniMargaret M. Dyson Vision Research Institute, Department of Ophthalmology, Weill Cornell Medical College, New York, NY 10065.
Shima FukuokaMargaret M. Dyson Vision Research Institute, Department of Ophthalmology, Weill Cornell Medical College, New York, NY 10065.
Gemstonn AlegreMargaret M. Dyson Vision Research Institute, Department of Ophthalmology, Weill Cornell Medical College, New York, NY 10065.
Mark I RosenblattMargaret M. Dyson Vision Research Institute, Department of Ophthalmology, Weill Cornell Medical College, New York, NY 10065 mrosenbl@uic.edu.
Cornell University · US

Funding

Mechanisms of Corneal Nerve RepairR01EY018594 · NEI · WEILL MEDICAL COLL OF CORNELL UNIV · PI ROSENBLATT, MARK I · 2010 to 2014
$2.1M
Corneal Metalloproteinase-Matrix InteractionsK08EY015829 · NEI · WEILL MEDICAL COLL OF CORNELL UNIV · PI ROSENBLATT, MARK I · 2005 to 2009
$980k
NEI NIH HHS K08 EY015829NEI NIH HHS K08EY015829NEI NIH HHS R01 EY018594NEI NIH HHS R01EY018594
6 · The paper itself

Abstract

VEGF-B primarily provides neuroprotection and improves survival in CNS-derived neurons. However, its actions on the peripheral nervous system have been less characterized. We examined whether VEGF-B mediates peripheral nerve repair. We found that VEGF-B induced extensive neurite growth and branching in trigeminal ganglia neurons in a manner that required selective activation of transmembrane receptors and was distinct from VEGF-A-induced neuronal growth. VEGF-B-induced neurite elongation required PI3K and Notch signaling. In vivo, VEGF-B is required for normal nerve regeneration: mice lacking VEGF-B showed impaired nerve repair with concomitant impaired trophic function. VEGF-B treatment increased nerve regeneration, sensation recovery, and trophic functions of injured corneal peripheral nerves in VEGF-B-deficient and wild-type animals, without affecting uninjured nerves. These selective effects of VEGF-B on injured nerves and its lack of angiogenic activity makes VEGF-B a suitable therapeutic target to treat nerve injury.

Indexed as

AnimalsBlotting, WesternCell ProliferationCells, CulturedCell SurvivalCorneaMice, Inbred C57BLMice, KnockoutMice, TransgenicMicroscopy, FluorescenceNerve RegenerationNeuritesNeuronsPeripheral Nerve InjuriesPeripheral NervesPhosphatidylinositol 3-KinasesPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktReceptors, NotchVascular Endothelial Growth Factor BVascular Endothelial Growth Factor Receptor-1corneanerve injuryneuronal growthVEGF-B

Identifiers

PMID25404333
PMCPMC4260560
OpenAlexW2030360092

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.